Enanta Pharmaceuticals (ENTA) Other Working Capital Changes (2012 - 2026)
Enanta Pharmaceuticals' (ENTA) quarterly Other Working Capital Changes came in at -$533000.0 in Q1 2026, down 124.68% YoY from $2.2 million in Q1 2025, and up 36.09% on a QoQ basis from -$834000.0 in Q4 2025.
Enanta Pharmaceuticals (ENTA) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 15 years of Other Working Capital Changes data on file, last reported at -$533000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 124.68% year-over-year to -$533000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.5 million (down 190.51% YoY) and the FY2025 annual result came in at $29000.0, up 106.71% from the prior year.
- Other Working Capital Changes rose to -$533000.0 in Q1 2026, from -$834000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.5 million in Q4 2022 to a low of -$4.2 million in Q4 2025.
- A 5-year average of -$276235.3 and a median of -$1.6 million in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 17766.67% — and 2025, when it tumbled 20950.0%.
- Tracing ENTA's Other Working Capital Changes over 5 years: stood at -$40000.0 in 2022, then tumbled by 2457.5% to -$1.0 million in 2023, then soared by 100.39% to $4000.0 in 2024, then plunged by 20950.0% to -$834000.0 in 2025, then surged by 36.09% to -$533000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$533000.0 (Q1 2026), -$834000.0 (Q4 2025), and -$1.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 769,000.00 |
| Jun 30, 2026 | 769,000.00 |
| Jun 30, 2026 | 769,000.00 |
| Mar 31, 2026 | 2.47 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Dec 31, 2025 | -4.25 Mn |
| Dec 31, 2025 | -4.25 Mn |
| Dec 31, 2025 | -4.25 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | -1.73 Mn |
| Dec 31, 2024 | -1.73 Mn |